Suggestions
John Wilson
Founder and CEO in Cell and Gene Therapy Manufacturing
John Wilson is a prominent figure in the cell and gene therapy manufacturing industry. Here are the key details about him:
Professional Background
John Wilson is the Founder, CEO, and VP of Quality at CellReady, a company he established in May 2023.1 CellReady is designed to accelerate the development of cell and gene therapy (CGT) companies by providing essential resources and expertise.1
Other Roles and Ventures
- Wilson Wolf Manufacturing Corporation: Founder and CEO since 1995
- ScaleReady: Co-Founder and Board Member since January 20201
- Wilson Foundation Minnesota: Founder and Board Member since 20221
Expertise and Contributions
John Wilson has made significant contributions to the field of cell and gene therapy manufacturing:
- He is known for inventing and developing the G-Rex® technology, widely recognized as a leading platform for cell and gene therapy scale-up and scale-out.
- Through Wilson Wolf, he has been instrumental in creating devices for various CGT applications, including CAR, CTL, NK, Treg, TIL, and Neo-Antigen therapies.
- His work aims to simplify and improve the manufacturing processes for cell and gene therapies, making them more practical and cost-effective.23
Educational Background
John Wilson holds the following degrees:
- Mechanical Engineering BS from the University of Minnesota
- Business Administration BA from Hamline University
- Economics BA from Hamline University2
Industry Impact
Wilson's companies and initiatives have had a significant impact on the CGT industry:
- ScaleReady, a joint venture he co-founded, focuses on revolutionizing CGT manufacturing.1
- CellReady aims to cut development time and costs for CGT companies, potentially saving them years and millions of dollars in the process.1
- He has been involved in launching grant programs to support CGT development and manufacturing, such as the $20 Million G-Rex® Grant Program announced in 2024.4
John Wilson's LinkedIn username is john-wilson-b778884, as mentioned in the query.
Highlights
May 29 · prnewswire.com
ScaleReady Announces $20 Million G-Rex® Grant Program for the ...
May 29 · PR Newswire
ScaleReady Announces $20 Million G-Rex® Grant Program for the Advancement of Cell and Gene Therapy (CGT ... - PR Newswire